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Objective: To evaluate the antioxidative and anticataractogenic potential effect of ursodeoxycholic acid (UDCA) on
selenite-induced cataract in vitro and in vivo.
Methods: Enucleated rat lenses were incubated in M199 medium alone (Group I), with 200 μM selenite (Group II), or
with 200 μM selenite and 500 μM UDCA (Group III). Selenite was administered on the third day and UDCA treatment
was from the second to the fifth day. The development of cataracts was observed under an inverted microscope. Total
antioxidative  capabilities  (T-AOC),  mean  activities  of  superoxide  dismutase  (SOD),  catalase  (CAT),  glutathione
peroxidase (Gpx), glutathione reductase (GR) and glutathione S-transferase (GST), levels of reduced glutathione (GSH),
malondialdehyde (MDA), and total sulfhydryl content were analyzed in lenticular samples. In vivo, cataracts were induced
in 12-day-old pups by single subcutaneous injections of sodium selenite. The test groups received 180 mg/kg bodyweight/
day of UDCA intraperitoneally on postpartum days 11–16 or 0.5% UDCA drops four times daily on postpartum days 11–
25.
Results: In vitro, morphological examination of the lenses revealed dense vacuolization and opacification in Group II,
minimal vacuolization in 12.5% of Group III, and no opacification in 87.5% of Group III. In Group I, all lenses were clear.
UDCA significantly (p<0.05) restored GSH and total sulfhydryl, and decreased MDA levels. T-AOC and the mean
activities of the antioxidant enzymes were elevated following treatment with UDCA. In vivo, 0.5% UDCA drops resulted
in only 20% nuclear cataract development and 180 mg/kg of UDCA intraperitoneally led to 50% development, compared
to 100% in the control group (p<0.05).
Conclusions:  UDCA  prevents  selenite  toxicity  and  cataractogenesis  by  maintaining  antioxidant  status  and  GSH,
protecting the sulfhydryl group, and inhibiting lipid peroxidation in lenses.
Cataracts are the leading cause of irreversible blindness
worldwide [1]. Over 50 million people worldwide suffer from
cataracts and the number will increase as individuals in the
current generation grow older [2,3]. Currently, the only cure
for cataracts is surgical removal of the opaque lenses and
substitution with clear ones. However, this operation is not
equally available to all and an artificial lens does not have the
overall optical qualities of a normal lens [4]. Preventing or
delaying  the  onset  of  cataracts  by  pharmacological
approaches may lessen this burden, reduce the occurrence of
sightlessness, and enhance the quality of life for much of the
world’s older, and diabetic populations [5].
Both epidemiological and experimental studies provide
evidence that oxidative stress is a major mechanism in the
initiation  and  progression  of  cataracts  [6,7].  Accordingly,
lenses have evolved antioxidant systems to defend against the
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toxic  damage  of  reactive  oxygen  species  (ROS)  or  free
radicals, including antioxidants, such as reduced glutathione
(GSH),  and  antioxidant  enzymes  such  as  superoxide
dismutase (SOD), catalase (CAT), glutathione S-transferase
(GST),  and  glutathione  reductase/peroxidase  (GR/Gpx)
[8-10]. Selenite-induced cataracts have been widely used to
study  mechanisms  of  cataract  formation  and  to  screen
potential anti-cataract agents [5]. Several studies [11,12] have
shown positive associations between antioxidant intake and
reduced incidence or progression of nuclear cataracts.
The use of bear bile has been practiced in China and other
Asian countries for thousands of years [13]. China’s State
Pharmacopoeia  lists  approximately  28  types  of  medicines
containing bear bile, 15 of which are used in ophthalmology
[14]. Ursodeoxycholic acid (UDCA) is the pharmacologically
active  ingredient  contained  in  bear  bile.  It  has  been
synthetized  from  cholic  acid  and  approved  by  the  health
administrations  of  several  countries  for  treatment  of  liver
diseases and gallstones [15,16]. UDCA has been proved to
prevent  the  oxidative  injury  induced  by  several  agents,
through a direct antioxidant effect or an increase in antioxidant
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151defenses [17]. Perez et al. [18] found that UDCA treatment
during pregnancy prevented oxidative injury in the placenta
and fetal liver [19] by upregulating the activities of catalase,
glutathione  peroxidase,  and  glutathione-S-transferase,
increasing GSH content and the GSH/glutathione disulfide
ratio,  and  reducing  oxidative  stress-induced  apoptosis.
Mulhern et al. [20] showed that tauroursodeoxycholic acid
(TUDCA), another form of the bile acid components, could
suppress  lens  epithelial  cell  death  and  alleviate  cataract
formation  in  galactosemic  rat  lenses  though  alleviating
endoplasmic reticulum (ER) stress. Song et al. [21] suggested
that UDCA protected the chaperone activity of α-crystallin in
human lens. Today, UDCA is produced and marketed by
several  manufacturers  worldwide  because  of  its  powerful
antioxidant activity, its ability to be well tolerated, and its low
toxicity [15]. Furthermore, the above findings may lead to the
development of UDCA as an anticataract agent. Therefore,
the authors of this paper proposed that the antioxidant action
of UDCA could contribute to beneficial effects in cataract
patients. No previous work has studied the effects of UDCA
on oxidative stress or on the activities of antioxidant enzymes
in cataracts. The present study employed a selenite-induced
cataractogenesis  model  to  test  the  hypothesis  that  UDCA
could  retard  cataract  formation  and  modulate  antioxidant
status in vitro and in vivo.
METHODS
Reagents: M-199 culture medium, fetal bovine serum (FBS)
and antibiotic solution were purchased from Gibco (Grand
Island,  NY).  Sodium  selenite  was  obtained  from  Sigma
Chemical Company (St. Louis, MO). UDCA was purchased
from Amresco Inc. (Solon, OH). Culture plates were acquired
from  Corning  Inc.  (Corning,  NY).  Protein  and  enzyme
quantification  kits  were  obtained  from  Jiancheng
Bioengineering Institute (Nanjing, China).
Lens culture and grouping: Lenses were obtained from the
eyes of 5-week-old male Wistar rats (Institute of Experimental
Animals, Harbin Medical University) by a posterior approach
under deep anesthesia. Animal care and protocols were in
accordance with and approved by the Institutional Animal
Ethics Committee. Lenses were cultured in M-199 medium
supplemented  with  20  mM  HEPES,  10%  heat-inactivated
(56  °C  for  0.5  h)  fetal  bovine  serum  (FBS),  100  U/ml
penicillin,  and  0.1  mg/ml  streptomycin  at  37  °C  in  a
humidified atmosphere of 5% CO2 as described previously
[22]. Lenses were placed in individual wells of 24-well culture
dishes  containing  1  ml  medium/well  for  five  days;  those
developing opacification in the first 24 h were discarded.
Previous studies have shown that these culture conditions
maintain lens vitality over 96 h without significant changes in
cellular biochemical indexes, such as sodium pump activity
and protein synthesis [22,23].
Lenses were grouped as follows with eight lenses in each
group: Group I, cultured in a normal medium alone (normal
control); Group II, cultured in a medium supplemented with
sodium selenite (cataract-untreated); and Group III, cultured
in a medium supplemented with sodium selenite and UDCA
(cataract-treated).  UDCA  treatment  (500  μM)  was
administered to Group III from the second to the fifth day
while selenite administration (200 μM) to Group II and Group
III was on the third day. Selenite sodium was dissolved in
saline (150 mM NaCl) and UDCA was dissolved in a solution
at pH 8.3 (NaCl 150 mM, Na2CO3 100 mM) [24]. During and
at the termination of the experiment, lenses were observed for
cataract  formation  using  an  inverted  microscope  (at  40×,
100×, and 200×).
Preparation  of  lenses  for  analysis:  The  lenses  from  each
group were homogenized in 0.9% neutral normal sodium (w/
v 1:9), and centrifuged at 2,200× g for 15 min at 4 °C. The
supernatant obtained was stored at −80 °C in aliquots, pending
further analysis. Protein in each sample was estimated by the
Coomassie brilliant blue method, using BSA as a standard.
Analysis of each antioxidant parameter was repeated three
times.
Measurement of total antioxidative capability (T-AOC): The
T-AOC  was  measured  by  the  ferric  reducing-antioxidant
power (FRAP) assay method [25]. The ferric ion (Fe+3) was
reduced to ferrous (Fe+2) form by an antioxidative substance
in the supernatant, and the color that developed was detected
at 520 nm with a spectrophotometer. The result was expressed
as units/mg protein and one unit of T-AOC was equal to a 0.01
increase in absorbance of the reaction mixture at 520 nm per
milligram protein per min under 37 °C incubation.
Assay of antioxidant enzymes activity:
Superoxide dismutase—Superoxide dismutase (SOD)
activity in lens homogenate was assayed by using a previously
reported method [26]. The degree of inhibition of 4-nitro-blue
tetrazolium  chloride  (NBT)  using  the  xanthine-xanthine
oxidase system was measured. The change of optical density
was read spectrophotometrically at 560 nm. The amount of
enzyme that inhibited NBT by 50% was defined as one unit
of SOD activity. Results were expressed as units/mg protein.
Catalase—Catalase (CAT) activity was assayed at 25 °C
by the method introduced by Pedraza-Chaverrí et al. [27],
based  on  the  direct  measurement  of  H2O2  decomposition.
Researchers started the reaction by adding 20 μl of the sample
to 3 ml of H2O2. The change of optical density was read
spectrophotometrically  at  240  nm.  The  decomposition  of
H2O2 by CAT presented in the supernatant followed a first-
order kinetic reaction, as given by the equation k=2.303/t log
A0/A60, where k is the first-order reaction rate constant, t is the
time over which the disappearance of H2O2 was measured (60
s), and A0/A60 is the optical density at times 0 and 60 s,
respectively. The result was expressed as units/g protein and
one  unit  of  CAT  activity  represented  1  mmol  H2O2
decomposition per sec.
Glutathione  peroxidase—The  activity  of  glutathione
peroxidase (Gpx) was determined, essentially, as described by
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by the Gpx present in the supernatant, with H2O2 as a cofactor,
was determined. The change in absorbance was read against
a reagent blank at 412 nm on a spectrophotometer. In the
present tests, the enzyme activity was expressed as units/mg
protein.  One  unit  activity  was  defined  as  the  amount  of
enzyme that converted 1 μmol of reduced glutathione (GSH)
to the oxidized form of glutathione (GSSH) in the presence of
H2O2/min.
Glutathione  reductase—The  activity  of  glutathione
reductase (GR) was assayed by the procedure of Linetsky et
al.  [29].  The  principle  of  this  method  is  that  GR  utilizes
nicotinamide adenine dinucleotide phosphate (NADPH) to
convert oxidized glutathione to its reduced form. The reaction
was initiated by the addition of 20 μl of lens homogenate. The
decrease in optical density was read at 340 nm for 2 min at
intervals of 30 s with a spectrophotometer. The enzymatic
activity  was  calculated  using  an  extinction  coefficient  of
6.22 mM/cm for NADPH and it was expressed as mmol of
NADPH oxidized/min/g protein.
Glutathione S-transferase—The activity of glutathione
S-transferase (GST) was measured according to the procedure
developed by Habig et al. [30]. The conjugation of GSH with
1  chloro  and  2–4  dinitrobenzene  (CDNB)  was  observed
spectrophotometrically  at  412  nm.  One  unit  of  GST  was
defined  as  the  enzyme  concentration  required  to  reduce
1 μmol GSH in one min.
Estimation of malondialdehyde content: The extent of lipid
peroxidation was determined by the Bhuyan et al. method
[31]. Briefly, 0.2 ml of 8.1% sodium dodecyl sulfate, 1.0 ml
of 50% acetic acid, and 1.5 ml of 0.81% thiobarbituric acid
aqueous  solution  were  added  in  succession.  Approximate
0.1 ml of the homogenate was combined with the mixture and
the  mixture  then  boiled  for  80  min.  The  supernatant  was
separated after cooling by centrifugation at 4,000× g for 10
min and the intensity of the resulting pink color was read
spectrophotometrically at 532 nm against a blank without
tissue  homogenate.  Tetramethoxypropane  was  used  as  an
external standard. The level of lipid peroxide was expressed
as nmoles of MDA formed/mg protein.
Estimation  of  reduced  glutathione  and  total  sulfhydryl
content: The GSH content was estimated by the method of
Hissin  et  al.  [32].  Trichloroacetic  acid  was  added  to  the
lenticular homogenate and the supernatant was obtained by
centrifugation of the sample. This supernatant (100 μl) was
then mixed with 300 μl of 0.6 M Na2HPO4 and 100 μl 0.04%
(w/v) 5, 5′-dithiobis-nitrobenzoic acid (DTNB). The resulting
yellow color was read at 412 nm on a spectrophotometer. GSH
standards  were  run  simultaneously.  The  results  were
expressed in μmol/mg protein.
Briefly,  the  total  sulfhydryl  content  was  determined
according to the description of the kit. The yellow compound
given by the reaction of sulfhydryls and DTNB had a high
absorption of light at 412 nm. The content of total sulfhydryl
in each lens (from GSH and protein) was measured by this
colorimetric method.
In vivo studies: Wistar rat pups were divided into control
(Group I), cataract-untreated (Group II), and cataract-treated
(Group III and Group IV) groups. In each group (n=10), pups
were housed with their mothers under standard conditions and
the mothers were given normal rat chow and water ad libitum.
On postnatal day 12, pups in Groups II, III, and IV received a
single injection of 20 μmol/kg bodyweight sodium selenite
subcutaneously, while those in Group I received only saline.
One drop 0.5% UDCA was instilled every 6 h (four times
daily) into the eyes of pups in the group III, starting one day
before the sodium-selenite injection (on postpartum day 11),
and the schedule continued for 14 days (until postpartum day
25). The 0.5% UDCA drop was at a 5 mg/ml concentration,
dissolved in a solution at pH 8.3 containing NaCl 150 mM and
Na2CO3 100 mM. Pups in Group IV received intraperitoneal
injections (180 mg/kg bodyweight) of UDCA on postpartum
days 11–16. The incidence of cataracts was viewed by an
operating  microscope  after  dilating  the  pupil  with  1%
tropicamide on postpartum day 25.
Statistical analysis: For the continous variables (in vitro data),
the data were expressed as mean±SD, and statistics of the data
used the one-way ANOVA analysis. When ANOVA results
showed statistically significant differences, post hoc testing
was performed for intergroup comparisons using the least
significant difference (LSD) test. The χ2 test was applied for
the  categorical  variables  (in  vivo  data).  A  p<0.05  was
considered  significant.  All  statistical  calculations  were
computed  by  the  Statistical  Package  for  Social  Science
(SPSS) version 11.0 (SPSS Science, Chicago, IL).
RESULTS
Lens  morphology  in  vitro:  At  the  termination  of  the
experiment,  all  the  lenses  in  Group  I  exhibited  complete
transparency.  All  the  lenses  in  Group  II  exhibited  dense
cortical  vacuolization  and  lenticular  opacification.  The
majority of lenses (87.5% on average) in Group III were
transparent and the remainder developed lesser amounts of
cortical vacuolization when supplemented with UDCA. The
results  showed  UDCA  could  prevent  the  formation  of
vacuoles and opacity to a great extent (Figure 1).
Total antioxidative capability in lenses: The T-AOC in lenses
treated with selenite was significantly decreased compared to
the control (p<0.05). The T-AOC in the lenses of Group III
was significantly higher than that in Group II rat lenses, but it
was lower than that in Group I (p<0.05; Figure 2).
Activities of antioxidant enzymes:
Superoxide dismutase—The activity of SOD in Group
II significantly decreased following selenite administration
compared  to  the  control  (p<0.05),  while  treatment  with
UDCA in Group III was found to maintain significantly higher
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3A).
Catalase—The activity of CAT in Group II significantly
decreased following selenite administration compared to the
control (p<0.05), while treatment with UDCA in Group III
was found to maintain significantly higher levels of CAT
activity compared to Group II (p<0.05; Figure 3B).
Figure 1. Rat lenses in various groups. A, B, and C are normal lenses; D, E, and F are selenite-induced lenses, and G, H, and I are selenite +
UDCA-induced lenses. The magnification of A, D, and G is 40×; the magnification of B, E, and H is 100× and the magnification of C, F,
and I is 200×.
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II significantly decreased following selenite administration
compared  to  the  control  (p<0.05),  while  treatment  with
UDCA in Group III was found to maintain significantly higher
levels of Gpx activity compared to Group II (p<0.05; Figure
3C).
Glutathione reductase—The activity of GR in Group II
significantly  decreased  following  selenite  administration
compared  to  the  control  (p<0.05),  while  treatment  with
UDCA in Group III was found to maintain significantly higher
levels of GR activity compared to Group II (p<0.05; Figure
3D).
Glutathione  S-transferase—The  activity  of  GST  in
Group  II  significantly  decreased  following  selenite
administration  compared  to  the  control  (p<0.05),  while
treatment with UDCA in Group III was found to maintain
Figure  2.  T-AOC  in  the  lens  of
experimental groups. Group I: Control.
Group  II:  Selenite-supplemented.
Group  III:  Selenite-supplemented  +
UDCA treated. Values are expressed as
mean±SD.  Statistics  of  the  data  used
one-way ANOVA followed by the least
significant  difference  (LSD)  test.  *
Compared  with  Group  I:  p<0.05.  #
Compared with Group II: p<0.05.
Figure 3. Activities of antioxidant enzymes in lenticular samples. A: Activity of SOD in lens. B: Activity of CAT in lens. C: Activity of Gpx
in lens. D: Activity of GR in lens. E: Activity of GST in lens. Group I: Control. Group II: Selenite-supplemented. Group III: Selenite-
supplemented + UDCA treated. Values are expressed as mean±SD. Statistics of the data used one-way ANOVA followed by the least significant
difference (LSD) test. * Compared with Group I: p<0.05. # Compared with Group II: p<0.05.
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II (p<0.05; Figure 3E).
Levels of malondialdehyde in lenses: MDA, an indicator of
lipid  peroxidation,  was  significantly  elevated  following
selenite  induction  in  Group  II  compared  to  the  control
(p<0.05),  while  UDCA  treatment  showed  a  significant
reduction in the levels of MDA in Group III compared to
Group II (p<0.05; Figure 4).
Levels of reduced glutathione and total sulfhydryl content in
lenses:  Remarkable  decreases  in  GSH  levels  and  total
sulfhydryl content were found in Group II lenses compared to
the control, while GSH levels and total sulfhydryl content
were  elevated  with  UDCA  treatment  when  compared  to
Group II (Figure 5).
Effect on selenite cataract: In vivo: All pups that received
normal saline exhibited complete transparency of the lens.
Subcutaneous  injections  of  sodium  selenite  led  to  the
development of 100% nuclear opacities in the lens of Group
II on postnatal day 25. In contrast, 0.5% UDCA drops led to
40% of the eyes being clear, 40% having pinpoint opacity, and
only  20%  developing  nuclear  cataracts.  180  mg/kg  of
intraperitoneal UDCA resulted in 20% of the eyes being clear,
30% having pinpoint opacity, and 50% developing nuclear
cataracts (Table 1). Lenses in the eyes of the Wistar rat pups
from different groups are demonstrated in Figure 6.
DISCUSSION
Oxidative  stress  has  been  implicated  in  many  disease
processes, especially in age-related disorders, such as age-
related cataracts [33]. Antioxidant systems that consist of non-
enzymatic and enzymatic components protect the lens from
oxidative damage and maintain lens clarity. UDCA has been
proved to have antioxidant properties both in vitro [34] and in
vivo [35,36]. The current study is the first to evaluate the
anticataract  potential  of  UDCA  against  selenite-induced
cataracts. The results showed that pretreatment with UDCA
could retard cataract formation and inhibit oxidative stress in
the selenite cataract model, in vitro and in vivo.
Figure  4.  Levels  of  MDA  (a  lipid
peroxidation  product  index)  in  lens.
Group  I:  Control.  Group  II:  Selenite-
supplemented.  Group  III:  Selenite-
supplemented + UDCA treated. Values
are expressed as mean±SD. Statistics of
the  data  used  one-way  ANOVA
followed  by  the  least  significant
difference (LSD) test. * Compared with
Group  I:  p<0.05.  #  Compared  with
Group II: p<0.05.
Figure 5. The levels of reduced GSH and
total Sulfhydryl content in lens. Group
I:  Control.  Group  II:  Selenite-
supplemented.  Group  III:  Selenite-
supplemented + UDCA treated. Values
are expressed as mean±SD. Statistics of
the  data  used  one-way  ANOVA
followed  by  the  least  significant
difference (LSD) test. * Compared with
Group  I:  p<0.05.  #  Compared  with
Group II: p<0.05.
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156Selenite-induced  cataracts  exhibit  many  general
similarities to human cataracts, such as increased calcium,
protein aggregation, decreased water-soluble proteins, and
reduced glutathione levels [37]. They have received much
attention and been the objects of model system work in the
field of oxidative stress-induced cataracts. The characteristic
is cortical vacuolization and opacification in vitro, while it is
a nuclear cataract in the in vivo rat pup model. The underlying
mechanisms of the development of both opacifications have
been found to be similar [22]. Therefore, the lens opacification
observed in vivo can be mimicked in vitro by the addition of
Na2SeO3  to  the  culture  medium  [5].  Due  to  the  special
anatomic structure and efficient protective mechanisms in the
eye, systemically and topically administered drugs have poor
access to the eye [38]. To target lens successfully, the organ-
cultured  rat  lens  was  used  as  the  model  to  study  the
biochemical  basis  for  UDCA  protective  functions  against
selenite-induced cataract in vitro. Furthermore, the UDCA
protective effects were confirmed with in vivo experiments.
Alleviation  of  cataract  formation  was  observed  in
cultured lenses with UDCA pretreatment. This observation
may  be  attributed  to  the  improved  antioxidant  status.
Mitsuyoshi et al. [39] established the free-radical scavenging
effects  of  UDCA  by  measuring  the  levels  of  glutathione
(GSH) and thiol-containing proteins in hepatocytes; this was
further confirmed by measuring MDA, TAOC, SOD, CAT,
GSH-Px, GR and GST activities in this study.
Antioxidant enzymes such as SOD, CAT, and GSH-Px
are present in all parts of the lens [40]. They can scavenge
formed ROS. Superoxides can first be degraded into hydrogen
peroxide (H2O2) by SOD, and subsequently, catalyzed into
ground-state oxygen and water by catalase and enzymes of the
glutathione redox cycle, including glutathione reductase (GR)
and  glutathione  peroxidase  (Gpx)  [41].  Although  the
individual  contribution  of  each  of  these  enzymes  in  the
detoxification of H2O2 is not clear, they are generally thought
to work cooperatively. At low levels of H2O2, the glutathione
redox cycle is responsible for protecting against H2O2-induced
damage  and  maintaining  high  levels  of  GSH  in  the  lens,
whereas, at a higher concentration, the principal mechanism
for the removal of H2O2 is catalase [42]. Many in vitro studies
[43,44] have established that GR can affect cation transport
systems, lens hydration, sulfhydryl groups of proteins, and
membrane integrity. GST, a typical multifunctional enzyme,
is  also  viewed  as  a  defense  mechanism  against  lipid
peroxidation. It plays a role in the hydrophobic compounds as
a thioltransferase-like redox regulator [45]. In the present
study, the mean activities of SOD, CAT, Gpx, GR, and GST
significantly decreased in the lenses of the cataract-untreated
group (Group II), compared with normal control (Group I) rat
lenses. In lenses treated with UDCA, the mean activities of
TABLE 1. MORPHOLOGICAL EXAMINATION OF LENSES OF RAT PUPS IN THE IN VIVO STUDY.
Groups Clear Pinpoint opacity Nuclear cataract
Group I 10 (100%) 0 0
Group II 0 0 10 (100%)
Group III 4 (40%)*† 4 (40%)*† 2 (20%)*†
Group IV 2 (20%)*† 3 (30%)*† 5 (50%)*†
        Data are presented as N (%); Statistics analysis was by χ2 test; Group I: normal control; Group II: cataract-untreated; Group III:
        cataract treated with 0.5% UDCA drops; Group IV: cataract treated with 180 mg/kg bodyweight UDCA intraperitoneal
        injections. * Compared with Group I: p<0.05; † Compared with Group II: p<0.05.
Figure 6. Appearance of lenses in eyes of Wistar rat pups. A: Lenses in normal (Group I) pup eyes: clear. B: Lenses in cataract-untreated
(Group II) pup eyes: nuclear cataracts. C: Lenses in some pup eyes treated with UDCA drop (Group III): clear. D: Lenses in some pup eyes
treated with intraperitoneal UDCA (Group IV): pinpoint opacity.
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with lenses in Group II. A similar result was found in the
studies by Perez et al. [18,19], in which they demonstrated
that UDCA increased the antioxidant enzyme levels in the
placenta and fetal liver of rats with maternal cholestasis. The
present study also assayed T-AOC levels to evaluate total
antioxidative  capacity:  when  the  lenses  were  treated  with
UDCA, T-AOC levels were elevated. The results indicated
that  UDCA  enhancement  of  lenticular  total  antioxidant
capacity  might  include  nonenzymatic  and  enzymatic
antioxidant systems.
GSH, which is highly concentrated in the lens and helps
to reduce proteins [46,47], contains a side chain of sulfhydryl
(-SH) residue that enables it to protect cells against oxidants.
Reduced levels of GSH have been observed in cataractous
lenses  [47].  The  present  investigation  found  that  UDCA
significantly restored the levels of GSH and total sulfhydryl
(from GSH and protein) in cultured rat lenses. The present
findings  corroborate  earlier  studies  where  UDCA
significantly restored GSH levels in isolated rat hepatocytes
[40] and in rats with bile-duct-ligation-induced secondary
biliary cirrhosis [36]. The enhancement of glutathione levels
can  be  included  among  the  beneficial  effects  of  UDCA
treatment  and  may  be  due  to  a  higher  expression  of  the
enzymes  involved  in  glutathione  synthesis  [17].
Malonedialdehyde (MDA) is a product of the breakdown of
mainly  unsaturated  fatty  acids  into  their  essential  chains
through the oxidation mechanism. It is accepted as a reliable
marker  of  the  lipid  peroxidation  that  occurs  because  of
oxidative stress. In the present study, UDCA decreased MDA
levels in the lens. These results confirmed the antioxidative
effect  of  UDCA  on  selenite-administered  lenses.  Similar
findings regarding the effect of UDCA on lipid peroxidation
were  reported  by  Ljubuncic  et  al.  [48]  in  cultured
macrophages and by Jüngst et al. [49] in gallbladder bile.
Selenite  cataracts  can  be  produced  in  suckling  rats
between postnatal days 10 to 14, five to six days after a single
injection of selenite. The present investigation confirmed that
both  topical  administration  of  0.5%  UDCA  and
intraperitoneal administration of UDCA 180 mg/kg into rat
pups could prevent selenite-induced cataract formation. The
dose of UDCA was based on the results of the pilot study.
However,  the  incidence  rate  of  lens  opacity  with  UDCA
treatment in vivo was higher, compared to that in vitro. The
authors of this paper suspect that this may be ascribed to the
transport properties of UDCA into the eyes.
In conclusion, the study showed that UDCA delayed the
progression of lens opacification in selenite-induced cataracts
in vitro and in vivo. UDCA may serve as an antioxidant agent,
increase  the  levels  of  GSH,  protect  the  sulfhydryl  group,
maintain  antioxidant  enzyme  activities,  and  inhibit  lipid
peroxidation, thus protecting lens transparency. Therefore,
research on the mechanisms of UDCA provides an important
experimental base for potential drug therapies for cataracts. It
remains to be determined whether UDCA is limited in its
transport into the eyes. Further research is needed to evaluate
the transport properties of UDCA and to enhance its ocular
bioavailability.
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